Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis
- PMID: 9952216
- DOI: 10.1023/a:1026629528233
Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis
Abstract
Extraintestinal manifestations in patients with inflammatory bowel disease (IBD) are quite common (about 25%) and careful clinical observation and statistical analysis during the last five decades have demonstrated that in colitis-associated extraintestinal complications, the organs most commonly involved are the biliary tract, joints, skin, and eyes. However, almost all organs can be involved in IBD. Some of the extraintestinal manifestations may precede IBD, although the majority accompany the underlying disease and are influenced by its activity. Prompt recognition of extracolonic organ involvement in IBD is important because of the relative refractoriness of the disease and a possible increase in morbidity and mortality. The identified pathogenetic autoimmune mechanisms include genetic susceptibility, cytokine imbalances, antigenic display of autoantigen, aberrant self-recognition, and immunopathogenetic autoantibodies against organ-specific cellular antigen(s) shared by colon and extracolonic organs. Microbes may play an important role, probably by molecular mimicry.
Similar articles
-
Extra intestinal manifestations and complications in inflammatory bowel disease.Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):279-88. Rev Med Chir Soc Med Nat Iasi. 2014. PMID: 25076688 Review.
-
Extraintestinal manifestations in inflammatory bowel disease.World J Gastroenterol. 2005 Dec 14;11(46):7227-36. doi: 10.3748/wjg.v11.i46.7227. World J Gastroenterol. 2005. PMID: 16437620 Free PMC article. Review.
-
Pathogenesis and clinical approach to extraintestinal manifestations of inflammatory bowel disease.Minerva Gastroenterol Dietol. 2007 Sep;53(3):233-48. Minerva Gastroenterol Dietol. 2007. PMID: 17912186 Review.
-
Extraintestinal manifestations of inflammatory bowel disease.Minerva Gastroenterol Dietol. 2005 Jun;51(2):147-63. Minerva Gastroenterol Dietol. 2005. PMID: 15990704 Review.
-
Extraintestinal and systemic manifestations of inflammatory bowel disease.Med Clin North Am. 1990 Jan;74(1):39-50. doi: 10.1016/s0025-7125(16)30585-5. Med Clin North Am. 1990. PMID: 2404180 Review.
Cited by
-
Autoantibodies pANCA, GAB and PAB in inflammatory bowel disease: prevalence, characteristics and diagnostic value.Wien Klin Wochenschr. 2010 May;122 Suppl 2:19-25. doi: 10.1007/s00508-010-1344-y. Wien Klin Wochenschr. 2010. PMID: 20517666
-
Current issues in pediatric inflammatory bowel disease-associated arthropathies.World J Gastroenterol. 2014 Jan 7;20(1):45-52. doi: 10.3748/wjg.v20.i1.45. World J Gastroenterol. 2014. PMID: 24415857 Free PMC article. Review.
-
Targeting Remission in Moderate-to-Severe Crohn's Disease.P T. 2018 Jun;43(6):358-361. P T. 2018. PMID: 29896035 Free PMC article.
-
Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease.Dig Dis Sci. 2007 Jan;52(1):18-24. doi: 10.1007/s10620-006-9361-4. Epub 2006 Dec 8. Dig Dis Sci. 2007. PMID: 17160479 Review. No abstract available.
-
Occurrence of skin manifestations in patients of the Swiss Inflammatory Bowel Disease Cohort Study.PLoS One. 2019 Jan 25;14(1):e0210436. doi: 10.1371/journal.pone.0210436. eCollection 2019. PLoS One. 2019. PMID: 30682031 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources